Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04197583 · ClinicalTrials.gov registry record
Double-J PLUS Postmarket Registry Study
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 379
- Enrollment target
NCT04197583: Completed study, sponsored by Boston Scientific Corporation.
NCT04197583 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 379 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04197583 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 379 participants
- Enrollment target
Study Summary
A multi-center global registry to obtain post-market safety and efficacy data on Boston Scientific Ureteral and Urinary Diversion Stents
Primary Outcome
Technical success was defined as: a stented kidney drains (to bladder) during the planned indwell time with no re-intervention due to obstruction of the stented ureters.
Interventions
- DEVICE Boston Scientific Ureteral Stents, Urinary Diversion Stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 379 participants |
| Start Date | 2020-02-19 |
| Est. Completion | 2023-02-22 |
What the finished NCT04197583 record still lists
NCT04197583 is an observational study that tracks outcomes without assigning an intervention. The registered 379 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Boston Scientific Ureteral Stents, Urinary Diversion Stent is the first listed.
NCT04197583 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04197583 about?
NCT04197583 is a clinical study titled "Double-J PLUS Postmarket Registry Study". A multi-center global registry to obtain post-market safety and efficacy data on Boston Scientific Ureteral and Urinary Diversion Stents
What is the current status of trial NCT04197583?
This trial is currently completed. The enrollment target is 379 participants. The study started on 2020-02-19. Estimated completion is 2023-02-22.
What interventions are being tested in trial NCT04197583?
The interventions under investigation include: Boston Scientific Ureteral Stents, Urinary Diversion Stent (DEVICE).
Who is sponsoring clinical trial NCT04197583?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
- NCT04777357 · 380 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- NCT04821154 · 380 participants
Persona Revision Knee System Outcomes
- NCT05102019 · 380 participants · NA
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI